Clinical Trial Update: Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test [Phase 2]

View source ↗

Summary

Phase 2 trial investigating safety and efficacy of varying doses of RagweedMATAMPL with assessment of residual allergenicity via skin prick test for Type I hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type Hypersensitivity

Drugs mentioned

• RagweedMATAMPL

Snippet

Sponsor: Allergy Therapeutics | Conditions: Type I Hypersensitivity | Phase 2 | Status: COMPLETED